A study to determine number of events of Haematochezia associated with vedolizumab using data from FDA Adverse Event Reporting System (FAERS)
Latest Information Update: 10 Dec 2020
At a glance
- Drugs Vedolizumab (Primary)
- Indications Crohn's disease; Ulcerative colitis
- Focus Adverse reactions
- 10 Dec 2020 New trial record